ISSN 2226-6976 (Print)
ISSN 2414-9640 (Online)

Experience with pre-exposure prophylaxis for HIV infection in Russia: results of a longitudinal sociological study

Nesterov R.S., Popova A.A.

1) Federal Research Sociological Center of the Russian Academy of Sciences, Moscow, Russia; 2) Central Research Institute of Epidemiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being, Moscow, Russia; 3) Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russia, Moscow, Russia
HIV infection is a serious challenge to global public health. Despite significant advances in HIV prevention, testing, and treatment, the incidence of the disease continues to rise, negatively impacting public health.
Objective. Assessment of the need for pre-exposure prophylaxis (PrEP) for HIV in Russia among men with risky sexual behavior.
Materials and methods. From 2021 to 2025, monitoring at the Charitable Foundation for Support of Social Initiatives and Public Health was conducted. The study included surveys of individuals who initiated HIV PrEP at four checkpoints: baseline, 3, 6, and 12 months.
Results. Overall PrEP adherence demonstrated a steady increase: from 76.5% in 2021 to 96.1% in 2025. Concurrently, the proportion of respondents using a situational medication regimen increased: from 63.2% in 2021 to 88.4% in 2025.
Conclusion. The study demonstrated high demand for HIV PrEP programs among key populations and identified key trends related to adherence, motivation, behavior patterns, and barriers to PrEP use.

Keywords

pre-exposure prophylaxis
PrEP
HIV
prevention
monitoring and evaluation

References

1. Ладная Н.Н., Покровский В.В. Эпидемиологическая ситуация по инфекции, вызванной ВИЧ, в России в 2024 г. Эпидемиол. инфекц. болезни. Актуал. вопр. 2025; 15(3): 13–18. [Ladnaya N.N., Pokrovskiy V.V. Epidemiological situation of HIV infection in Russia in 2024. Epidemiology and Infectious Diseases. Current Issues. 2025; 15(3): 13–18 (In Russ.)]. DOI: 10.18565/epidem.2025.15.3.13-18

2. Покровский В.В., Ладная Н.Н., Соколова Е.В. ВИЧ-инфекция. Информационный бюллетень № 50. М., 2025. 79 с. [Pokrovskiy V.V., Ladnaya N.N., Sokolova E.V. HIV Infection. Information Bulletin № 50. Moscow, 2025. 79 p. (In Russ.)].

3. Нестеров Р.С., Попова А.А., Назарова И.Б. Работа с социальным окружением ВИЧ-положительных людей по прерыванию передачи ВИЧ-инфекции. Инфекционные болезни: мультидисциплинарный взгляд. Материалы науч.-технич. конф. с международным участием. Санкт-Петербург, 15–16 апреля 2025 г. СПб.: Человек и его здоровье, 2025: 118–124. [Nesterov R.S., Popova A.A., Nazarova I.B. Working with the Social Environment of People Living with HIV to Interrupt HIV Transmission. In: Infectious Diseases: A Multidisciplinary Perspective. Materials of the Scientific and Technical Conference with International Participation. Saint Petersburg, April 15–16, 2025. SPb: Man and his health, 2025: 118–124. (In Russ.)].

4. Попова А.А., Харламова Т.В., Голиусова М.Д., Борисова А.К., Беляев В.В., Кузнецов И.И. и др. Информированность о ВИЧ-инфекции основной инструмент прекращения эпидемии (результаты пилотного исследования в Московском регионе) Инфекционные болезни: мультидисциплинарный взгляд Материалы научно-технической конференции с международным участием, Санкт-Петербург, 15–16 апреля 2025 г. СПб.: Человек и его здоровье, 2025: 129–135. [Popova A.A., Kharlamova T.V., Goliusova M.D., Borisova A.K., Belyaev V.V., Kuznetsov I.I. et al. Awareness of HIV infection as the main tool for ending the epidemic (results of a pilot study in the Moscow region). In: Infectious Diseases: A Multidisciplinary Perspective. Materials of the Scientific and Technical Conference with International Participation. Saint Petersburg, April 15–16, 2025. SPb: Man and his health 2025: 129–135. (In Russ.)].

5. Шилов А.М., Попова А.А., Пучкова Л.М., Покровская А.В. Особенности медицинских консультаций людей, уязвимых в отношении ВИЧ-инфекции, по направлению из неправительственных организаций. Журнал инфектологии 2024; 16(2): 200–205. [Shilov A.M., Popova A.A., Puchkova L.M., Pokrovskaya A.V. Features of medical consultations for people vulnerable to HIV infection referred from non-governmental organizations. Journal Infectology 2024; 16(2): 200–205. (In Russ.)].

6. Su S., Wei Y., Dong W., Sun J., Li Y., Zhang W. et al. Epidemiological impacts and cost-effectiveness of daily and on-demand oral pre-exposure prophylaxis among key HIV populations in China: An economic evaluation. Epidemiol. Infect. 2025; 153: e95. DOI: 10.1017/S026095882510068X

7. Dietrich J., Ahmed A., Tshabalala G., Wu M., Mulaudzi M., Hornschuh S. et al. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe. PLoS One 2023; 18: e0287627. DOI: 10.1371/journal.pone.0287627

8. Koppe U., Marcus U., Albrecht S., Schmidt D., Bremer V., Zimmermann R. et al. Factors associated with the informal use of HIV pre-exposure prophylaxis in Germany: a cross-sectional study. J. Int. AIDS Soc. 2019; 22(10): e25395. DOI: 10.1002/jia2.25395.

9. Куимова У.А., Беляева В.В., Козырина Н.В., Попова А.А., Шилов А.М., Покровская А.В. и др. Оценка информированности о методе доконтактной профилактики ВИЧ-инфекции медицинских специалистов, студентов медицинских вузов и волонтеров благотворительного фонда. Эпидемиол. инфекц. болезни. Актуал. вопр. 2022; 12(3): 54–58. [Kuimova U.A., Belyaeva V.V., Kozyrina N.V, Popova A.A., Shilov A.M., Pokrovskaya A.V. et al. Assessment of awareness of the method of pre-exposure prophylaxis of HIV infection among medical specialists, medical students and volunteers of a charitable foundation. Epidemiology and infectious diseases. Current items 2022; 12(3): 54–58. (In Russ.)]. DOI: 10.18565/epidem.2022.12.3.54-8

10. Попова А.А., Домонова Э.А., Скачкова Т.С., Куимова У.А., Козырина Н.В., Беляева В.В. и др. Результаты обследования представителей уязвимых групп на вирус простого герпеса вне медицинских учреждений (результаты пилотного исследования по двум регионам России). Эпидемиол. инфекц. болезни. Актуал. вопр 2024; 14(3): 60–66. [Popova A.A., Domonova E.A., Skachkova T.S., Kuimova U.A., Kozyrina N.V., Belyaeva V.V. et al Results of a survey of representatives of vulnerable groups for herpes simplex virus outside medical institutions (results of a pilot study in two regions of Russia). Epidemiology and infectious diseases. Current items 2024; 14(3): 60–66. (In Russ.)]. DOI: 10.18565/epidem.2024.14.3.60-66

11. Покровский В.В., Юрин О.Г., Кравченко А.В., Беляева В.В., Куимова У.А., Шилов А.М. и др. Рекомендации по лечению ВИЧ-инфекции и связанных с ней заболеваний, химиопрофилактике заражения ВИЧ. Эпидемиол. инфекц. болезни. Актуал. вопр. 2025; 15(4, приложение): 105 с. [Pokrovskiy V.V., Yurin O.G., Kravchenko A.V., Belyaeva V.V., Kuimova U.A., Shilov A.M. et al. Recommendations for the treatment of HIV infection and related diseases, chemoprophylaxis of HIV infection. Epidemiology and infectious diseases. Current items 2025; 15(4, аpplication). 105 р. (In Russ.)].

About the Authors

Roman S. Nesterov, Cand. Sociol, Sci., Research, Federal Research Center of the Russian Academy of Sciences, Moscow, Russia; r_s_nesterov@mail.ru; https://orcid.org/0000-0001-6492-2985
Anna A. Popova, Cand. Med. Sci., Senior Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being; Associate Professor, Department of Infectious Diseases, Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russia, Moscow, Russia; asya-med@mail.ru; https://orcid.org/0000-0001-9484-5917

Similar Articles